D
Candel Therapeutics, Inc. CADL
$5.02 $0.6013.58% NASDAQ
Recommendation
Prev Close
$5.02
Volume
200
Avg Vol (90D)
739,979
Market Cap
$275.59M
Dividend & Yield
--
52-Week Range
$4.25 - $14.60
P/E (TTM)
--
EPS (TTM)
-$0.56
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Candel Therapeutics (CADL, $4.42) Aroon Indicator entered a Downtrend on December 02, 2025.
12/3/2025 - Tickeron - Stocks
Candel Therapeutics (CADL, $4.48) entered Downtrend as Momentum indicator drops below 0 level on Dec 01, 2025
12/2/2025 - Tickeron - Stocks
Candel Therapeutics (CADL, $4.48) Aroon Indicator entered a Downtrend on December 01, 2025.
12/2/2025 - Tickeron - Stocks
Candel Therapeutics (CADL, $4.77) entered Uptrend as Momentum indicator ascends above 0 level on Nov 28, 2025
11/29/2025 - Tickeron - Technical Analysis
Candel Therapeutics (CADL, $4.77) Aroon Indicator entered a Downtrend on November 28, 2025.
11/29/2025 - Tickeron - Technical Analysis
Candel Therapeutics (CADL, $4.77) Stochastic Oscillator left the oversold zone on November 28, 2025
11/29/2025 - Tickeron - Technical Analysis
Candel Therapeutics (CADL, $4.62) Aroon Indicator entered a Downtrend on November 26, 2025.
11/27/2025 - Tickeron - Technical Analysis
Candel Therapeutics (CADL, $4.47) Aroon Indicator entered a Downtrend on November 25, 2025.
11/26/2025 - Tickeron - Stocks
Candel Therapeutics (CADL, $4.53) Aroon Indicator entered a Downtrend on November 24, 2025.
11/25/2025 - Tickeron - Stocks
Candel Therapeutics (CADL, $4.55) Aroon Indicator entered a Downtrend on November 21, 2025.
11/22/2025 - Tickeron - Stocks
Candel Therapeutics (CADL, $4.55) RSI Indicator left the oversold zone on November 21, 2025
11/22/2025 - Tickeron - Stocks
Candel Therapeutics (CADL, $4.42) Aroon Indicator entered a Downtrend on November 20, 2025.
11/21/2025 - Tickeron - Stocks
Candel Therapeutics (CADL, $4.42) RSI Indicator left the oversold zone on November 19, 2025
11/20/2025 - Tickeron - Stocks
Candel Therapeutics (CADL, $4.42) Aroon Indicator entered a Downtrend on November 19, 2025.
11/20/2025 - Tickeron - Stocks
Candel Therapeutics (CADL, $4.62) Aroon Indicator entered a Downtrend on November 18, 2025.
11/19/2025 - Tickeron - Stocks
Candel Therapeutics (CADL, $4.73) Aroon Indicator entered a Downtrend on November 17, 2025.
11/18/2025 - Tickeron - Stocks
Candel Therapeutics (CADL, $4.73) RSI Indicator left the oversold zone on November 17, 2025
11/18/2025 - Tickeron - Stocks
Candel Therapeutics to Host Virtual R&D Event on December 5, 2025
11/17/2025 - GuruFocus
Candel Therapeutics to Host Virtual R&D Event on December 5, 2025
11/17/2025 - Globe Newswire
Citigroup Cuts Candel Therapeutics (NASDAQ:CADL) Price Target to $24.00
11/16/2025 - MarketBeat
Candel Therapeutics (NASDAQ:CADL) Rating Lowered to "Sell" at Wall Street Zen
11/16/2025 - MarketBeat
Candel Therapeutics (CADL) Analyst Rating Update: Citigroup Lowers Price Target CADL Stock News
11/14/2025 - GuruFocus
Citigroup Cuts Candel Therapeutics (NASDAQ:CADL) Price Target to $24.00
11/14/2025 - Ticker Report
Candel Therapeutics (NASDAQ:CADL) Issues Quarterly Earnings Results, Misses Estimates By $0.04 EPS
11/14/2025 - MarketBeat
Candel Therapeutics (CADL) Pauses CAN-2409 Development for Specific Cancer Indication
11/14/2025 - GuruFocus
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$38.99M
EBIT (TTM)
-$39.91M
Net Income (TTM)
-$22.76M
Balance Sheet
Total Assets (Q)
$93.60M
Total Debt (Q)
$7.21M
Total Liabilities (Q)
$13.47M
Book Value Per Share (Q)
$1.46
Cash Flow
Cash from Operations (TTM)
-$33.56M
Cash from Investing (TTM)
-$154.00K
Cash from Financing (TTM)
$104.12M
Net Change in Cash (TTM)
$70.41M
Filings
Filing Date
Thursday, November 13, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Mar 9 and 13 (est)
Price History
Loading...
Beta
1.30
7-Day Total Return
10.82%
30-Day Total Return
-4.56%
60-Day Total Return
3.51%
90-Day Total Return
-23.59%
Year to Date Total Return
-44.16%
1-Year Total Return
13.32%
2-Year Total Return
457.78%
3-Year Total Return
161.46%
5-Year Total Return
--
52-week Low
Apr 09, 2025 - $4.25
52-week High
Dec 11, 2024 - $14.60
Valuation
Market Cap
$275.59M - Micro Cap
Enterprise Value
$195.83M
Price/Sales (TTM)
--
Price/Book (Q)
3.44
Dividends and Shares
Shares Outstanding
54.89
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.candeltx.com
Phone Number
617 916 5445
Address
117 Kendrick Street
Needham, MA 02494
Country
United States
Year Founded
2003
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies for the cancer patients. It develops CAN-2409, which is in Phase III clinical trials for the... more
NASDAQ 12/03/2025 4:00PM Eastern Quotes delayed